Various fused oxazine such as 4-(4-methoxyphenyl)-3,7-dimethyl-1,4-dihydro-5H-pyrazolo [4 ,3 :5,6] 
Introduction
Heterocyclic compounds are one of the most important molecules in the synthesis of pharmacologically active compounds [1] [2] [3] [4] . Enaminonitriles have been utilized as starting materials for synthesis of huge number of heterocyclic compounds containing pyranopyrimidine [5] [6] [7] [8] [9] and pyridopyrimidine [10] [11] [12] [13] moieties. Oxazines [14] and quinazolines [15] are natural products which exhibit a widespread spectrum of biological activity including antitumor [16] [17] [18] , antiinflammatory [19] , and antiplatelet [20] properties. In view of these reports and as a continuation of our previous work on heterocyclic chemistry [21] [22] [23] [24] [25] [26] [27] , we aimed to incorporate the pyrano moiety into the 1,5-position of oxazinone and pyrimidinone ring systems to obtain new heterocyclic system which is anticipated to possess notable chemical and pharmacological activities. So we utilized enaminonitrile in the synthesis of pyrano [2,3-d] [1, 3] oxazin-5-one derivative and pyrano [2,3-d] pyrimidine and pyrano [2,3-d] pyrimidine-5-one derivatives in addition to studying their antioxidant activities.
Results and Discussion

Chemistry.
Our present investigation aimed to synthesize of 6-amino-4-(4-methoxyphenyl)-3-methyl-1,4-dihydropyrano [2,3-c] pyrazole-5-carbonitrile [28] , which was used as a precursor for the synthesis of previously unreported 4-(4-methoxyphenyl)-3,7-dimethyl-1,4-dihydro-5H-pyrazolo [4 ,3 :5,6] pyrano [2,3-d] [1, 3] oxazin-5-one as new heterocyclic compound containing oxazine and pyranopyrazole moieties. Compound has been prepared by fourcomponent one-pot reaction [29] and three-component onepot reaction [30] (Scheme 1).
Treatment of by freshly distilled acetic anhydride afforded as a sole product. The structure of was elucidated by spectral analysis. The IR spectrum showed a strong absorption band at 1732 cm −1 corresponding to lactonic carbonyl group and the disappearance of the cyano group. Also the structure was confirmed by elemental analysis; 1 H-NMR spectrum showed a singlet at 12.52 ppm of NH, a doublet at 7.162-7.136 ppm and 6.84-6.81 ppm of aromatic protons, a singlet at 4.7 ppm of benzylic proton, and a singlet at 3.68 ppm of three protons for OCH 3 group. Acetylation of by refluxing with acetic anhydride gave the diacetyl derivative and not the expected triazolo derivative . The structure of was confirmed by the spectral data such as the IR which showed the absorbance for the carbonyl group at 1732 and 1695 cm −1 and the two methyl groups signals at 2.678 ppm for 2CH 3 in 1 H-NMR spectrum (Scheme 3).
Pharmacological
Activity. Antioxidant activity using 2,2 -azinobis(3-ethylbenzothiazoline-6-sulfonic acid) (ABTS) inhibition. The prepared compounds were tested for antioxidant activity as reflected in their ability to inhibit oxidation in rat brain and kidney homogenates, from the result in Table 1 . Compounds , , a, and exhibit a similar antioxidant activity to ascorbic acid, used as standard. Compounds and exhibited moderate antioxidant activity, while , , b, , and showed lower activity.
Bleomycin Dependent DNA Damage. The bleomycins are a family of glycopeptides antibiotics [31] that are routinely used as antitumor agents. The bleomycin assay has been adopted for assessing the prooxidant activity of food antioxidants. The antitumor antibiotic bleomycin binds iron ions and DNA. If the samples are able to reduce bleomycin-Fe 3+ to bleomycin-Fe, DNA degradation in the system will be stimulated, resulting in a positive test for prooxidant activity. DNA 
degradation is accompanied by the formation of a product similar to malondialdehyde. L-Ascorbic acid was used as the reducing agent to reduce Fe 3+ to Fe 2+ . The synthesized compounds were selected for bleomycin dependent DNA damage testing (Table 1) .
Results in Table 1 showed that compounds , , a, , and have the ability to protect DNA from the damage induced by bleomycin. On the other hand, the rest of the compounds exhibited weak activities.
Cytotoxic Activity of Some Compounds against Human Tumor
Cells. The prepared compounds were tested for cytotoxic activity against four human tumor cells. Best results were observed for compounds , , a, and which were found • IC50 ( g/ml): 1-10 (very strong), 11-20 (strong), 21-50 (moderate), 51-100 (weak), and above 100 (noncytotoxic); 5-FU = 5-fluorouracil.
to very strong cytotoxic compounds. Compound was also considered strongly cytotoxic. Finally, compounds , , and were moderate in their cytotoxic activity and compounds , b, and were weakly cytotoxic ( Table 2 ).
Experimental.
All melting points were measured on a Gallenkamp electric melting point apparatus and are uncorrected. The infrared spectra were recorded in potassium bromide disks on a pyeUnicam SP-3-300 and Shimdazu FTIR 8101 PC infrared spectrophotometers.
The 1 H-NMR and 13 C-NMR were recorded at a Varian Mercury VX-300 MHz and 75 MHz, respectively, using TMS as internal standard in deuterated chloroform (CDCl 3 ) or deuterated dimethyl sulfoxide (DMSO-d6). Chemical shifts are measured in ppm. The mass spectra were recorded on a Shimadzu GCMS-QP-1000EX mass spectrometer at 70 eV. Elemental analyses were carried out at the Microanalytical Center of Cairo University. All the reactions and the purity of the new compounds were followed and checked by TLC using TLC aluminum sheets silica gel F 254 .
Synthesis of 6-Amino-4-(4-methoxyphenyl)-3-methyl-1,4-dihydropyrano[2,3-c]pyrazole-5-carbonitrile ( )
Method 1. An equimolar mixture of anisaldehyde (10 mmol, 1.36 mL), ethyl acetoacetate (10 mmol, 1.3 mL), hydrazine hydrate (0.5 mL), and malononitrile (10 mmol, 0.66 g) was stirred for 30 min at room temperature in the presence of triethyl amine and water (5 ml). The precipitate was filtered off and recrystallized from ethanol, yield (81%).
Method 2.
A mixture of 3-methyl-5-pyrazolone (10 mmol, 0.98 g) and arylidine (10 mmol, 1.1 g) was refluxed in (30 mL) ethanol and 5 drops of piperidine for 2 h. The precipitate was filtrated off and recrystallized from ethanol to give solid 1, yield (87%). 
Synthesis of 4-(4-Methoxyphenyl)-3,7-dimethyl-4,6-dihydropyrazolo[4 ,3 :5,6]pyrano[2,3-d]pyrimidine-5-(1H)-one ( ).
A mixture of (10 mmol, 3.25 g) and formamide (10 mL) or excess ammonium acetate was refluxed for 4 h. After cooling white solid was collected, washed with water, dried, and recrystallized from benzene: ethanol mixture [4 ,3 :5,5] pyrano [3,2-d] [4 ,3 :5,6] pyrano [2,3-d] [4 ,3 :5,6] pyrano [2,3- 
Synthesis of 4-(4-Methoxyphenyl)-3,7-dimethyl-4-hydrobenzoimidazolo[1,2-c]pyrazolo
Synthesis of N-[4-(4-Methoxyphenyl)-3,7-dimethyl-5-oxo-1,4-dihydropyrazolo
Synthesis of 6-Amino-4-(4-methoxyphenyl)-3,7-dimethyl-4,6-dihydropyrazolo
d]pyrimidin-5(1H)-one ( ).
To a solution of (10 mmol, 3.25 g) in 20 mL of ethanol, hydrazine hydrate (0.5 mL) was added. The reaction mixture was refluxed for 4 h. The separated solid was filtered, dried, and recrystallized from ethanol to give ( ). 
General Procedure for the Synthesis of Pyrazolopyranopyrimidine ( a-c).
A solution of (10 mmol, 3.25 g) in dimethylformamide (20 mL) and (10 mmol) of 4-methyl aniline, 4-methoxyaniline, and/or 4-amino aniline was heated under reflux for 5 h. The solid that was separated out after concentration and cooling was recrystallized from the proper solvent to give ( a-c). [4 ,3 :5,6] pyrano [2,3- [4 ,3 :5,6] pyrano [2,3-d] -3,7-dimethyl-4,6-dihydropyrazolo[4 ,3 :5,6] pyrano [2,3- (20) , 77 (100). [4 ,3 :5,6] pyrano [2,3- 
4-(4-Methoxyphenyl)-3,7-dimethyl-6-(p-tolyl)-4,6-dihydropyrazolo
4,6-Bis(4-methoxyphenyl)-3,7-dimethyl-4,6-dihydropyrazolo
6-(4-Aminophenyl)-4-(methoxyphenyl)
Synthesis of 4-(4-Methoxyphenyl)-3,7-dimethyl-4,6-dihydropyrazolo
d]pyrimidine-5(1H)-thione ( ).
A mixture of (10 mmol, 3.4 g) and thiourea (10 mmol, 0.76 g) in ethanol (20 mL) was heated under reflux for 6 h. The separated solid was filtered, dried, and recrystallized from ethanol to give ( ). [4 ,3 :5,6] pyrano [2,3-d] 
Synthesis of 5-Chloro-4-(4-methoxyphenyl)-3,7-dimethyl-1,4-dihydropyrazolo
pyrimidine ( ).
A mixture of (10 mmol, 3.24 g), phosphorus oxychloride (15 mL), and phosphorus pentachloride (150 mmol, 3.13 g) was heated in water bath at 80 ∘ C for 8 h. The reaction mixture after cooling was poured onto crushed ice and the solid obtained was filtered off and recrystallized from ethanol to give pale brown solid ( ). [4 ,3 :5,6] pyrano [2,3-d] pyrimidine ( ). A mixture of (10 mmol, 3.4 g) and hydrazine hydrate (0.5 mL) in (30 mL) ethanol was heated under reflux for 5 h. The solid separated after concentration and cooling was filtered off and recrystallized from ethanol to give ( ). (2N,N-diacetylhydrazino)-4-(4-methoxyphenyl)-3,7-dimethyl-1,4-dihydropyrazolo [4 ,3 :5,6] pyrano [2, 3-d] pyrimidine ( ). A mixture of (10 mmol, 3.3 g) was heated under reflux with 30 mL of fresh distilled acetic anhydride for 8 h. The excess acetic anhydride was removed by distillation and the separated product was filtered off and recrystallized from ethanol to give ( ). 
Synthesis of 5-Hydrazino-4-(4-methoxyphenyl)-3,7-dimethyl-1,4-dihydropyrazolo
Synthesis of 5-
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